Protagonist Therapeutics
Price & Volume
Stats
See more52W Range | $33.70-$96.54 |
Market Cap | $5.5B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $209.2M |
Revenue Growth (YoY) | 0.8% |
Gross Profit (12 Mos) | $209.2M |
Diluted EPS | $0.66 |
News
See moreYahoo Finance • 23 days ago
Protagonist And Takeda Report 52-Week Rusfertide Data In Polycythemia Vera
Yahoo Finance • last month
Protagonist Therapeutics Reaches Analyst Target Price
Yahoo Finance • 2 months ago
Protagonist Therapeutics Says Icotrokinra Showed 'Meaningful' Outcomes in Ulcerative Colitis Phase 2 Trial
Yahoo Finance • 3 months ago
Protagonist Therapeutics falls amid a report J&J deal price may be lower
About
CEO | Dr. Dinesh V. Patel Ph.D. |
CFO | Mr. Asif Ali |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 128 |
